Stay updated on Avutometinib and Defactinib in Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Study locations updated to 7 sites. Some site contacts and location details were removed (e.g., Allentown, PA / Lehigh Valley contact information).
    Difference
    0.7%
    Check dated 2026-02-25T21:19:55.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page; the government funding lapse notice and related operating-status banner were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:47:53.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now displays a site-wide notice about a lapse in government funding and shows the site revision to v3.4.1, replacing v3.4.0. These changes are administrative and do not affect the study details, eligibility criteria, or outcomes.
    Difference
    0.4%
    Check dated 2026-02-04T10:29:47.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now displays a glossary toggle and updated footer information including Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0, replacing the previous labels Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T06:19:15.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Footer revision label updated to v3.3.4. The previous revision label v3.3.3 was removed.
    Difference
    0.0%
    Check dated 2026-01-14T01:48:51.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Locations section reorganized; New Jersey, New York, and Pennsylvania entries are consolidated under a general Locations heading, and the HHS Vulnerability Disclosure link was removed; the revision updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T10:19:04.000Z thumbnail image

Stay in the know with updates to Avutometinib and Defactinib in Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.